With more than $1B in Q3 profits, Express Scripts confident heading into Cigna merger

PILLS MONEY cost opioid
Express Scripts says it will be able to “offer greater affordability and differentiation” under Cigna's wing. (Pixabay)

Pharmacy benefit manager Express Scripts reported considerable growth in the third quarter of 2018 on Wednesday, with net income exceeding $1.07 billion, a 27.3% increase over the same quarter last year. 

Earnings per share reached $1.90 this past quarter, compared to $1.47 this time last year. In 2019, the company expects to grow core business adjusted claims by 2% to 3%, according to a press release.

The company has spent a considerable amount of time in the spotlight in recent months as the healthcare industry awaited the Department of Justice’s decision about its acquisition by Cigna. The department ultimately approved the move in September, and Cigna is now getting the green light from state regulatory agencies. On Thursday, Cigna CEO David Cordani said he anticipates the deal to close by the end of this year.

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

RELATED: The Department of Justice approved Cigna's acquisition of Express Scripts. What now?

Express Scripts President and CEO Tim Wentworth said his company’s “momentum is strong.” The deal with Cigna will allow Express Scripts to “offer greater affordability and differentiation” through cost containment, innovation, and improvements in patient care.

Express Scripts has also received attention this year for being the subject of multiple lawsuits. In July, online pharmacy CareZone accused Express Scripts of defamation and anticompetitive practices.

RELATED: With merger vote approaching, Cigna and Express Scripts diverge on value-based contracts

In September, the PBM was accused of overcharging patients for copies of their records, violating state and federal laws, in a class-action suit. But Wentworth said the company is working “to earn the trust of those we serve,” adding “With trust comes the ability to help even more people achieve better outcomes.”

The company did not hold an earnings call due to the Cigna deal. 

Suggested Articles

Even the highest performing physicians and practices will see a “piddly” payment adjustment under the Merit-based Incentive Payment System (MIPS).

Blue Cross and Blue Shield of North Carolina and Cambia Health Solutions have jointly decided to end their talks to enter a "strategic affiliation."

The Trump administration's new rules to overhaul the Stark Law have some areas that could create major regulatory headaches.